Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director | August 12, 2026 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date August 12, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,100 |
Reported balance
After 2026-08-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-12 · Sale · Disposed 1,717 · Balance 16,100 F1: The amount reported includes shares subject to unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The amount reported includes shares subject to unvested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2026 Filed Aug 13, 2026 21:09 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,717 | $133.00 | $228,361.00 |
DisclosureSEC source: 0001040470-26-000245 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,100 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 01:14 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000235 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,817 F1 · shares: The shares were donated to USA Triatholon Foundation. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 21:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 1,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000177 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,317 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 18:03 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000171 · primary_01.xml · nonDerivative · entry 3 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,659 F4 · shares: The shares were donated to San Mateo Community Colleges Foundation. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 18:03 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000171 · primary_01.xml · nonDerivative · entry 2 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,678 F3 · shares: The shares were donated to Peninsula Humane Society. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 18:03 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-26-000171 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,697 F1 · shares: The shares were donated to Pets in Need. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 16, 2026 Filed Apr 16, 2026 23:14 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 4,665 | $85.59 | $399,267.55 |
DisclosureSEC source: 0001040470-26-000114 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 0 Read SEC document |
| April 16, 2026 Filed Apr 18, 2026 00:03 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,716 | $81.54 | $139,922.64 |
DisclosureSEC source: 0001040470-26-000120 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,716 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| April 09, 2026 Filed Apr 11, 2026 01:05 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 3,000 | $68.36 | $205,072.50 |
DisclosureSEC source: 0001040470-26-000083 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 4,665 Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 19:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 140 | $31.49 | $4,407.90 |
DisclosureSEC source: 0001040470-26-000036 · primary_01.xml · nonDerivative · entry 5 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,432 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 19:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 100 | $31.46 | $3,146.00 |
DisclosureSEC source: 0001040470-26-000036 · primary_01.xml · nonDerivative · entry 4 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,572 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 19:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 180 | $31.45 | $5,661.00 |
DisclosureSEC source: 0001040470-26-000036 · primary_01.xml · nonDerivative · entry 3 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,672 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 19:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,026 | $31.44 | $32,257.44 |
DisclosureSEC source: 0001040470-26-000036 · primary_01.xml · nonDerivative · entry 2 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,852 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 19:19 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 3,100 | $31.38 | $97,278.00 |
DisclosureSEC source: 0001040470-26-000036 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,878 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 25, 2025 Filed Jul 25, 2025 21:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $21.50 | $107,501.50 |
DisclosureSEC source: 0001593968-25-000882 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 7,665 Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 21:43 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-25-000830 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,978 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 20:50 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000973 · primary_01.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,725 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 27, 2023 Filed Oct 28, 2023 01:46 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 4,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-013500 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 17,125 F1 · shares: One-eighth (1/8) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,008 | $52.50 | $52,920.00 |
DisclosureSEC source: 0001654954-23-010025 · section16.xml · nonDerivative · entry 4 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 12,665 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001654954-23-010025 · section16.xml · derivative · entry 6 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2026-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-23-010025 · section16.xml · derivative · entry 5 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2027-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 10,000 | $51.67 | $516,700.00 |
DisclosureSEC source: 0001654954-23-010025 · section16.xml · nonDerivative · entry 3 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.65 to $51.81, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 2,500 | $1.34 | $3,350.00 |
DisclosureSEC source: 0001654954-23-010025 · section16.xml · nonDerivative · entry 2 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 7,500 | $1.68 | $12,600.00 |
DisclosureSEC source: 0001654954-23-010025 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2023 Filed Jul 12, 2023 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-009082 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 13,673 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 504 | $33.89 | $17,080.56 |
DisclosureSEC source: 0001654954-23-001224 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 8,673 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:56 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 3,474 | $27.01 | $93,831.70 |
DisclosureSEC source: 0001654954-22-016086 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 9,177 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.000 to $27.025, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 23, 2022 Filed Nov 24, 2022 02:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,901 | $27.00 | $51,327.00 |
DisclosureSEC source: 0001654954-22-015718 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,651 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 6,731 | $25.00 | $168,275.00 |
DisclosureSEC source: 0001654954-22-015297 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 14,552 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 20:25 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,083 | $22.04 | $23,873.98 |
DisclosureSEC source: 0001654954-22-014237 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 21,283 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.04 to $22.045, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 24, 2022 Filed Oct 25, 2022 01:43 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,806 | $22.00 | $127,732.00 |
DisclosureSEC source: 0001654954-22-014086 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 22,366 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:08 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013923 · section16.xml · nonDerivative · entry 2 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 28,172 F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 23:08 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-013923 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 23,172 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 18:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 11,381 | $21.50 | $244,691.50 |
DisclosureSEC source: 0001654954-21-011590 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 21,010 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| October 19, 2021 Filed Oct 20, 2021 21:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 2,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-011235 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 32,391 F1 · shares: One-fourth (1/4) of the total number of shares subject to the restricted stock unit awards shall vest at the end of each three full calendar months following the date of this action, provided that such recipient still serves as a member of the Board of Director of the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 00:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001654954-21-009217 · section16.xml · derivative · entry 8 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 00:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001654954-21-009217 · section16.xml · derivative · entry 7 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 00:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-21-009217 · section16.xml · derivative · entry 6 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 7,500 shares Expires 2027-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 00:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 25,000 | $5.30 | $132,540.00 |
DisclosureSEC source: 0001654954-21-009217 · section16.xml · nonDerivative · entry 4 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.27 to $5.40, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 00:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 7,500 | $1.34 | $10,050.00 |
DisclosureSEC source: 0001654954-21-009217 · section16.xml · nonDerivative · entry 3 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 00:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 10,000 | $1.77 | $17,700.00 |
DisclosureSEC source: 0001654954-21-009217 · section16.xml · nonDerivative · entry 2 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 00:29 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 7,500 | $1.68 | $12,600.00 |
DisclosureSEC source: 0001654954-21-009217 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 20:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 18,456 | $5.75 | $106,122.00 |
DisclosureSEC source: 0001654954-21-008167 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 30,376 Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:31 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 5,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007933 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 48,832 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 21:38 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 6,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-004494 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 43,457 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 01:30 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 6,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-000670 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,726 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
| October 20, 2020 Filed Oct 21, 2020 23:57 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-20-011325 · section16.xml · derivative · entry 2 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-10-20 F2 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 20, 2020 Filed Oct 21, 2020 23:57 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 11,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-011325 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,837 F1 · shares: RSU shares issued in lieu of cash for BOD fee. Read SEC document |
| July 14, 2020 Filed Jul 17, 2020 00:26 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007786 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,456 F1 · shares: RSU shares issued in-lieu of cash for BOD fee. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 00:02 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 9,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-004293 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,451 F1 · shares: RSU shares issued in-lieu of cash for BOD fee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.